معرفی
Professor Christopher George is Professor of Molecular Cardiology in the Biomedical Sciences department at Swansea University Medical School, Faculty of Medicine, Health and Life Science. His research group employs molecular and cellular tools combined with network theory to investigate calcium signaling, cellular behavior, and the early events leading to cardiac arrhythmias.
George's research expertise spans molecular cardiology, calcium signaling, cardiac arrhythmias, stem cells, molecular biology, cell biology, systems biology, and drug screening technologies. His primary focus is on using experimental and clinical data to predict how heart cells respond to genetic mutations and drugs, with the goal of improving therapeutic approaches for genetic and acquired heart disease. His work integrates network theory with cellular approaches to understand cardiac electrophysiology at multiple scales.
Analysis of Professor George's recent publications reveals a consistent focus on cardiac calcium signaling mechanisms, particularly involving the ryanodine receptor (RyR2), with increasing interdisciplinary work spanning computational biology, toxicology, and pharmacological methodology. His research shows progression from fundamental molecular mechanisms toward translational applications, with recent work examining single-cell segmentation techniques, sex differences in pharmacological responses, and innovative approaches to cardiac modeling.
- Senior Editor at the British Journal of Pharmacology (cardiovascular portfolio)
- Member of editorial boards for Cardiovascular Research, Frontiers in Physiology, and Artery Research
- Board member of the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
- Chair of NC3Rs Grant Assessment Panel
- Chair of the National Cardiovascular Network for Wales (NCN)
- Active participant in developing international research guidelines (ARRIVE 2.0, sex as experimental variable)
Professor George's research is generously funded by major organizations including the British Heart Foundation, BBSRC, Wellcome Trust, MRC, Health and Care Research Wales, and the European Union. His collaborative approach is evident in numerous multi-institutional projects addressing cardiovascular disease mechanisms and therapeutic development. His leadership in the National Cardiovascular Network for Wales demonstrates his commitment to translating research findings into clinical practice within the Welsh healthcare system. While specific lab details aren't provided in the source material, his extensive publication record suggests an active research group focused on cardiac electrophysiology and molecular mechanisms of arrhythmia.
